Johnson & Johnson Stock Price Today: JNJ at $169.18

Market Highlights

• Current Price: $169.18
• 52-Week Range: $152.90 - $184.20
• Market Cap: $450.99 billion
• Dividend Yield: 2.63%

Factors Influencing Stock Price

1. Financial Performance

Johnson & Johnson (JNJ) recently reported strong financial results for the fourth quarter of 2022:

• Revenue: $24.75 billion, exceeding analyst estimates of $24.45 billion
• Net Income: $4.31 billion, increasing by 3.4% year-over-year
• Adjusted Earnings Per Share (EPS): $2.25, surpassing consensus estimates of $2.21

2. Pharmaceuticals Division

JNJ's pharmaceuticals division continues to drive growth. Key products include:

• Darzalex: A multiple myeloma treatment with $2.36 billion in sales in Q4
• Stelara: A psoriasis treatment with $2.15 billion in sales in Q4
• Invega Sustenna: A schizophrenia treatment with $1.08 billion in sales in Q4

3. Consumer Health Division

The consumer health division faces challenges, including intense competition and generic drug pressure. However, JNJ expects growth in its key brands:

• Tylenol: A pain reliever with $664 million in sales in Q4
• Band-Aid: A bandage brand with $440 million in sales in Q4
• Aveeno: A skincare brand with $385 million in sales in Q4

4. Healthcare Devices Division

JNJ's healthcare devices division is benefiting from increased demand for medical equipment. Key products include:

• Surgical Devices: Used in a wide range of surgeries, with $7.38 billion in sales in Q4
• Orthopedic Devices: Implants and other devices used in orthopedic surgeries, with $5.39 billion in sales in Q4
• Vision Care: Contact lenses, intraocular lenses, and other eye care products, with $3.27 billion in sales in Q4

Analyst Ratings

• Buy: 18 (64%)
• Hold: 9 (32%)
• Sell: 1 (4%)

Target Price

• Average Analyst Target Price: $178.27
• Highest Analyst Target Price: $200.00
• Lowest Analyst Target Price: $165.00

Technical Analysis

JNJ's technical indicators suggest a potential upside:

• Moving Averages: The 50-day moving average is trending above the 200-day moving average, indicating a positive momentum.
• Relative Strength Index (RSI): The RSI is above 50, indicating a strong bullish trend.
• Stochastic Oscillator: The stochastic oscillator is moving towards overbought territory, which could lead to a pullback in the short term.

Investment Thesis

Johnson & Johnson is a defensive stock with a track record of consistent performance. Its strong financial performance, diverse product portfolio, and pipeline of innovative products make it an attractive investment for long-term investors.

Table 1: JNJ Historical Stock Prices

Table 2: JNJ Financial Performance

Table 3: JNJ Products by Revenue

Table 4: JNJ Healthcare Devices by Revenue

Disclaimer:

This article is not intended as investment advice. It is for informational purposes only and should not be relied upon for investment decisions. Investors should conduct their own due diligence and consult with a financial professional before making any investment decisions.